An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging

• Binje Vick,

  Affiliations Group Apoptosis, Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Maja Rothenberg,

  Affiliation Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany

  ⨯
• Nadine Sandhöfer,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany, Clinical Cooperation Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Michela Carlet,

  Affiliation Group Apoptosis, Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Cornelia Finkenzeller,

  Affiliation Group Apoptosis, Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Christina Krupka,

  Affiliations Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany, Clinical Cooperation Group Immunotherapy, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Michaela Grunert,

  Affiliation Group Apoptosis, Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Andreas Trumpp,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM GmbH), Heidelberg, Germany

  ⨯
• Selim Corbacioglu,

  Affiliation Department of Pediatrics, University of Regensburg, Regensburg, Germany

  ⨯
• Martin Ebinger,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Pediatric Hematology/Oncology, University Children’s Hospital, Eberhard Karls Universität, Tuebingen, Germany

  ⨯
• Maya C. André,

  Affiliations Department of Pediatric Hematology/Oncology, University Children’s Hospital, Eberhard Karls Universität, Tuebingen, Germany, Department of Pediatric Intensive Care Medicine, University Children's Hospital (UKBB), Basel, Switzerland

  ⨯
• Wolfgang Hiddemann,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany, Clinical Cooperation Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Stephanie Schneider,

  Affiliation Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany

  ⨯
• Marion Subklewe,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany, Clinical Cooperation Group Immunotherapy, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Klaus H. Metzeler,

  Affiliations Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany, Clinical Cooperation Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
• Karsten Spiekermann,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität (LMU), Munich, Germany, Clinical Cooperation Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

  ⨯
•  [ ... ],
• Irmela Jeremias

  * E-mail: Irmela.Jeremias@helmholtz-muenchen.de

  Affiliations Group Apoptosis, Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Oncology, Dr von Haunersches Kinderspital, Ludwig Maximilians-Universität (LMU), Munich, Germany

  ⨯
• [ view all ]
• [ view less ]